What is HC Wainwright’s Estimate for Genmab A/S Q2 Earnings?
Genmab A/S (NASDAQ:GMAB – Free Report) – Investment analysts at HC Wainwright cut their Q2 2025 earnings per share estimates for shares of Genmab A/S in a research note issued on Wednesday, May 14th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of $0.41 per share for the quarter, down […]
Genmab A/S (NASDAQ:GMAB – Free Report) – Investment analysts at HC Wainwright cut their Q2 2025 earnings per share estimates for shares of Genmab A/S in a research note issued on Wednesday, May 14th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of $0.41 per share for the quarter, down […]
